Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Healthcare.
Press releases published on April 7, 2025
Avicanna Announces Receipt of Management Cease Trade Order and Provides Bi-Weekly Status Update
GlobeNewswire
·
April 7, 2025
Auditor Licensing …
StarMab BioMed’s First-in-Class, Dual-Target Anti-Tumor Drug SM2275 for Novel Immunotherapy Receives FDA IND Approval
EIN Presswire
·
April 7, 2025
StarMab announces that US FDA has approved its Investigational New Drug (IND) application for SM2275, a novel dual-target nanobody-based anti-tumor therapy. BEIJING, CHINA, April 7, 2025 /EINPresswire.com/ -- Beijing StarMab BioMed Technology , Ltd. (“ …
Jeune Aesthetics Appoints Marc Forth as Chief Executive Officer
GlobeNewswire
·
April 7, 2025
PITTSBURGH, April 07, 2025 (GLOBE NEWSWIRE) -- Jeune Aesthetics, Inc. (“Jeune”), a wholly owned subsidiary of Krystal Biotech, Inc. (“Krystal”) (NASDAQ: KRYS) leveraging Krystal’s clinically validated gene-delivery platform to fundamentally address and …
Oragenics, Inc. Participates in the 3rd Nasal Formulation & Delivery Summit
GlobeNewswire
·
April 7, 2025
SARASOTA, Fla., April 07, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biotechnology company focused on developing novel intranasal therapies for brain-related disorders, today announced that Chief Medical Officer Dr. James Kelly …
Pacira BioSciences Announces Settlement of U.S. Patent Litigation for EXPAREL
GlobeNewswire
·
April 7, 2025
-- Fresenius Kabi licensed to sell volume-limited amounts of generic bupivacaine liposome injectable suspension in the U.S. no earlier than a confidential date in 2030 -- -- Fresenius also licensed to sell generic bupivacaine liposome injectable suspension …
CareMed Has Been Selected as a National Specialty Pharmacy Partner for VANRAFIA™ (atrasentan)
GlobeNewswire
·
April 7, 2025
NEW HYDE PARK, N.Y., April 07, 2025 (GLOBE NEWSWIRE) -- CareMed, an independent specialty pharmacy, is in the Limited Distribution Network for Vanrafia™ (atrasentan), for the reduction of proteinuria in adults with primary immunoglobulin A nephropathy ( …
Abacus Global Management Well-Positioned Amid Market Volatility
GlobeNewswire
·
April 7, 2025
ORLANDO, Fla., April 07, 2025 (GLOBE NEWSWIRE) -- Abacus Global Management (“Abacus” or the “Company”) (NASDAQ: ABL), a leader in the alternative asset management space, commented on the ongoing macro environment, noting that it remains well-positioned to …
Solésence Announces Uplisting to Nasdaq
GlobeNewswire
·
April 7, 2025
Trading set to begin Tuesday, April 8 under new ticker “SLSN” ROMEOVILLE, Ill., April 07, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (OTCQB: NANX), a leader in scientifically-driven health care solutions across beauty and life science categories, today …
Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2025 Financial Results on May 8, 2025
GlobeNewswire
·
April 7, 2025
CANTON, Mass., April 07, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and …
Pliant Therapeutics Announces Upcoming Presentations at the 2025 American Thoracic Society International Conference
GlobeNewswire
·
April 7, 2025
SOUTH SAN FRANCISCO, Calif., April 07, 2025 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX) today announced that the Company will present three scientific posters at the upcoming 2025 American Thoracic Society (ATS) International Conference, …
CVRx Reports Preliminary First Quarter 2025 Financial Results
GlobeNewswire
·
April 7, 2025
MINNEAPOLIS, April 07, 2025 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company, today announced certain preliminary unaudited first quarter 2025 revenue results. “While we continue to make significant progress …
Clover Health Appoints Industry Veteran as Chief Medical Officer of Medicare Advantage
GlobeNewswire
·
April 7, 2025
WILMINGTON, Del., April 07, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced the appointment of Dr. Shelly Gupta as Chief Medical Officer (“CMO”). Dr. Gupta will oversee …
Tevogen Bio Highlights Most Recent Insider Ownership of 74%; Management Maintains Conviction in the Company’s Mission
GlobeNewswire
·
April 7, 2025
WARREN, N.J., April 07, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), a healthcare company with dedicated efforts in immunotherapy and artificial intelligence, is unified by a commitment to advancing patient- …
LeMaitre Will Announce First Quarter 2025 Earnings Results May 1, 2025
GlobeNewswire
·
April 7, 2025
BURLINGTON, Mass., April 07, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its first quarter 2025 financial results on Thursday, May 1, 2025, after the market close. The company has scheduled a …
Arialief Review (PATIENT RESULTS EXPOSED): What Happened After 30 Days on This Nerve Pain Formula?
GlobeNewswire
·
April 7, 2025
JUPITER, FL, April 07, 2025 (GLOBE NEWSWIRE) -- ARIALIEF Nerve pain is brutal. Whether it’s the persistent tingling, relentless burning, or sharp, electric jabs that come without warning—it can turn everyday life into a constant battle. More Than 30,000+ …
Inqtel Explores Potential in Cancer Therapy Research
EIN Presswire
·
April 7, 2025
Inqtel is engaged in preclinical cancer therapy research. SYDNEY, NEW SOUTH WALES, AUSTRALIA, April 7, 2025 /EINPresswire.com/ -- Inqtel Pty Ltd Announces Expansion into Cancer Therapeutics, Exploring Novel Treatment with Potential Inqtel Pty Ltd, an …
Moringa Magic (EXPOSED): Why Doctors Are Finally Taking This Superfood Seriously in 2025
GlobeNewswire
·
April 7, 2025
DENVER, CO, April 07, 2025 (GLOBE NEWSWIRE) -- MORINGA MAGIC In a health market flooded with overhyped wellness fads and questionable herbal blends, Moringa Magic is exploding in popularity—and not just because of the hype. Real users are now claiming …
MESA LABS DECLARES QUARTERLY DIVIDEND
GlobeNewswire
·
April 7, 2025
LAKEWOOD, Colo., April 07, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The …
Integral BioSystems Announces Fast-Track Drug Development Services for those Exploring Proof of their Concepts
EIN Presswire
·
April 7, 2025
Boston area contract drug delivery firm Integral BioSystems announces fast-track rapid development services for start-up companies and entrepreneurs! BEDFORD, MA, UNITED STATES, April 7, 2025 /EINPresswire.com/ -- Integral BioSystems LLC, Boston area …
Inmedix Recognized as the #1 ‘Most Valued Company’ at the Spring 2025 PNW & Rockies Keiretsu Forum Investor Capital Expo
EIN Presswire
·
April 7, 2025
Voted by angel investors as a stand-out innovator amongst a group of highly touted, growth-stage entrepreneurial companies from the U.S. and Canada NORMANDY PARK , WA, UNITED STATES, April 6, 2025 /EINPresswire.com/ -- Inmedix, Inc., developers of the …